Joseph Baroldi sold $743k of IONS
EVP, Chief Business Officer at IONIS PHARMACEUTICALS INC. 11,950 shares at an average of $62.16, traded Sep 9, 2025, filed Sep 11, 2025.
Score components
- +15RoleOfficer
- +21Trade size$743k at market
- +10Share of holdings soldSold 27% of holdings
- +15Cluster12 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000874015-25-000232, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 9, 2025 | MOption exercise Common Stock10b5-1 | +11,950 | $31.80 | $380k | 43,876 | Sep 11, 2025 |
| Sep 9, 2025 | SOpen-market sale Common Stock10b5-1 | -11,950 | $62.16 | $743k | 31,926 | Sep 11, 2025 |
| Sep 9, 2025 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -11,950 | $0.00 | $0 | 41,700 | Sep 11, 2025 |
Related signals
Other insiders at IONIS PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $6.7M 85,089 shares | -51% | |
| 18Weak | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $531k 6,659 shares | -15% | |
| 30Weak | IONIS PHARMACEUTICALS INC | Shannon L. Devers EVP, Chief Human Resources Ofc | $1.6M 20,106 shares | -47% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | Allene M. Diaz director | $4.4M 54,878 shares | -94% | |
| 40Moderate | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $7.1M 85,089 shares | -85% | |
| 48Moderate | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $488k 5,885 shares | -6% | |
| 52Moderate | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $439k 5,296 shares | -10% | |
| 48Moderate | IONIS PHARMACEUTICALS INC | Brian Birchler EVP, Corp and Development Ops | $513k 6,179 shares | -9% | |
| 29Weak | IONIS PHARMACEUTICALS INC | Shannon L. Devers EVP, Chief Human Resources Ofc | $323k 3,977 shares | -15% | |
| 35Weak | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $675k 8,977 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.